Computerized Cognitive Training in Breast Cancer Survivors

D
Diane Von Ah, PhD

Primary Investigator

Overview

This randomized clinical trial studies computerized cognitive retraining in improving cognitive function in breast cancer survivors.

Description

The purpose of this study is to conduct a home based single-blind, randomized controlled trial to test the feasibility, satisfaction, and preliminary efficacy of cognitive training delivered in the home setting compared to attention control in breast cancer survivors (BCS).

Eligibility

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    breast cancer
  • Age: Between 18 Years - 100 Years
  • Gender: All

Inclusion Criteria
Breast cancer (stage 0, I, II, III), 18 months to 5 years post oncologic therapies of surgery, chemotherapy, and/or radiation therapy (does not exclude current selective estrogen receptor modulators or aromatase inhibitors)
Able to read, write, and speak English
Have reliable internet and daily access to computer with audio/speakers
Agree to travel to the Seattle Cancer Care Alliance (SCCA) or University of Washington (UW) School of Nursing for 2-3 in person assessments over the 12-13 weeks of the study
Exclusion Criteria
History of multiple cancers
History of central nervous system (CNS) disease, CNS radiation, intrathecal therapy, or CNS surgery
History of traumatic brain injury
Neurologic disorders of stroke, encephalitis, dementia, epilepsy, Alzheimer's disease, Parkinson's disease
Self-report of learning disabilities
Substance addiction
Diagnosis of psychiatric disorders of psychosis, schizophrenia, or bipolar disorder
Previous participation in cognitive training program
Visual impairments such as uncorrected vision or color blindness
Uncorrected hearing impairments
Self-report that they are not pregnant or planning to become pregnant in the next four months
Anticipate moving from the region in the next 4 months
Inability to use a mouse or computer keys to navigate around the computer screen


Additional Information:
Participants will be paid for their participation.

Updated on 20 Nov 2022. Study ID: 1703775084 (IUSCC-0625)

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center